Medtronic, the global medical-device powerhouse that has been part of Santa Rosa’s business fabric for nearly thirty years, is preparing to shut down operations at its Fountaingrove campus and head out of town. The company told employees yesterday that it will gradually exit the site in a staged pullout set to wrap up in spring 2028, a move that puts about 370 local jobs at risk. Leadership has described the decision to employees as difficult but strategic, and said some positions will start shifting out as soon as next spring. The move effectively closes the book on almost three decades of cardiovascular work in the city and could significantly reorder Sonoma County’s advanced-manufacturing scene.
What Exactly Medtronic Is Shutting Down
According to The Press Democrat, roughly 370 employees in Santa Rosa were formally notified Thursday that Medtronic plans to relocate their work primarily to Mounds View, Minnesota, and Galway, Ireland. The company intends to wind down activity at its two-building Fountaingrove complex at 3540 and 3576 Unocal Place in phases, rather than in a single cut. The newspaper reports that some roles are scheduled to begin moving out next spring, with the final stage of the transition targeted for spring 2028.
A Global Giant Rewrites Its Map
Medtronic reported fiscal-year 2025 revenue of about $33.5 billion, with its coronary and peripheral vascular business bringing in roughly $2.5 billion last year, as detailed by Medtronic. Those numbers underscore just how large the company’s overall operation is compared with a single regional site. Against that backdrop, Medtronic is consolidating work into bigger hubs while still maintaining a global footprint, even if Santa Rosa now finds itself on the wrong side of that corporate map…